Imricor Medical Systems' Consumables Revenue Soars in Q4 2024; Shares Up 3%

MT Newswires Live

01/24

Imricor Medical Systems (ASX:IMR) reported an 840% year-on-year surge to AU$255,000 in its consumables revenue for the fourth quarter of 2024, according to a Thursday filing with the Australian bourse.

Total revenue reached AU$280,000, excluding the company's first capital sale in Qatar. The sale will be recognized in future quarters upon installation, per the filing.

Cash and cash equivalents at the end of the fourth quarter stood at $15.7 million.

The medical device maker's shares rose past 3% in recent Friday trade.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2505003419"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2505003419\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2505003419?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-24 11:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2505003419","market":"sh","top_or_hot":-1,"title":"Imricor Medical Systems' Consumables Revenue Soars in Q4 2024; Shares Up 3%","media":"MT Newswires Live","content":"<html><body><p> Imricor Medical Systems (ASX:IMR) reported an 840% year-on-year surge to AU$255,000 in its consumables revenue for the fourth quarter of 2024, according to a Thursday filing with the Australian bourse.</p><p>Total revenue reached AU$280,000, excluding the company's first capital sale in Qatar. The sale will be recognized in future quarters upon installation, per the filing.</p><p>Cash and cash equivalents at the end of the fourth quarter stood at $15.7 million.</p><p>The medical device maker's shares rose past 3% in recent Friday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Imricor Medical Systems' Consumables Revenue Soars in Q4 2024; Shares Up 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImricor Medical Systems' Consumables Revenue Soars in Q4 2024; Shares Up 3%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-01-24 11:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Imricor Medical Systems (ASX:IMR) reported an 840% year-on-year surge to AU$255,000 in its consumables revenue for the fourth quarter of 2024, according to a Thursday filing with the Australian bourse.</p><p>Total revenue reached AU$280,000, excluding the company's first capital sale in Qatar. The sale will be recognized in future quarters upon installation, per the filing.</p><p>Cash and cash equivalents at the end of the fourth quarter stood at $15.7 million.</p><p>The medical device maker's shares rose past 3% in recent Friday trade.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IMR.AU","symbol_name":"IMRICOR MEDICAL SYSTEMS-CDI","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2505003419","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2505003419","pubTimestamp":1737687867,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Imricor Medical Systems  reported an 840% year-on-year surge to AU$255,000 in its consumables revenue for the fourth quarter of 2024, according to a Thursday filing with the Australian bourse.Total revenue reached AU$280,000, excluding the company's first capital sale in Qatar. The sale will be recognized in future quarters upon installation, per the filing.Cash and cash equivalents at the end of the fourth quarter stood at $15.7 million.The medical device maker's shares rose past 3% in recent Friday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"IMR.AU":"IMRICOR MEDICAL SYSTEMS-CDI"},"translate_title":"Imricor Medical Systems 2024年第四季度耗材收入飙升；股价上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMR.AU":0.9},"content_text":"Imricor Medical Systems (ASX:IMR) reported an 840% year-on-year surge to AU$255,000 in its consumables revenue for the fourth quarter of 2024, according to a Thursday filing with the Australian bourse.Total revenue reached AU$280,000, excluding the company's first capital sale in Qatar. The sale will be recognized in future quarters upon installation, per the filing.Cash and cash equivalents at the end of the fourth quarter stood at $15.7 million.The medical device maker's shares rose past 3% in recent Friday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}